Main content
School of Nursing names new Associate Dean
Media Contact
J. Mike Moore
Director of Communications
Kim Jones

Kim Jones is a distinguished administrator and researcher with more than three decades of experience in nursing education and research. She most recently served as Dean of the School of Nursing at Linfield University in Portland, Oregon.

ATLANTA -- Emory University’s Nell Hodgson Woodruff School of Nursing has appointed Kim Dupree Jones PhD, RN, FNP, FAAN, a nationally renowned nurse scientist and educator, as the new Associate Dean of Academic Advancement.

Jones will begin her appointment on July 1, 2022.

Jones is a distinguished administrator and researcher with more than three decades of experience in nursing education and research. She most recently served as Dean of the School of Nursing at Linfield University in Portland. Prior to her appointment at Linfield University she was a full professor in the School of Nursing at Oregon Health and Sciences University.

"I am thrilled to welcome Dr. Jones to Emory," said Linda McCauley, dean and professor of Emory’s School of Nursing. "Dr. Jones has an impressive track record as a nurse researcher, educator and administrator. She is extremely well qualified to lead the school in the recruitment of outstanding faculty to the school and the support of resources to assure that all our faculty flourish at Emory University."

Jones is recognized as a leading expert in fibromyalgia, where her work is cited in national and international treatment guidelines and texts including "Up To Date, Cecil’s Textbook of Medicine," "Physical Rehabilitation & Medicine," and "Kelly’s Textbook of Rheumatology and Neurology in Clinical Practice." She is a co-author on The Revised Fibromyalgia Impact Questionnaire (FIQR), which is used extensively by major pharmaceutical companies including Pfizer, Lily, Cypress, Ortho, and Jazz pharmaceuticals as the first of the fibromyalgia-indicated drugs were tested and brough to the FDA. She also holds a patent for a genomics-based peripheral blood marker for fibromyalgia. Her most recent work has two foci: the role of cannabinoids in opioid taper, and photosensitivity as a novel mechanism engaging pain-modulating systems.

Dr. Jones is a prolific author with more than 120 publications and has completed more than 60 scientific studies on fibromyalgia to date with funding from the National Institutes of Health, the U.S. Department of Defense, multiple foundations and industry. She is recognized as a leading nurse researcher in pain management and is a fellow in the American Academy of Nursing and the Sigma Theta Tau International Nurse Researcher Hall of Fame.

"Faculty play a critical role in preparing the next generation of nurses for today's complex health care environment," Jones said. "I look forward to supporting the development of our faculty, so they can reach their highest potential and transform nursing science and education."


Recent News